J. Berg

458 total citations
12 papers, 256 citations indexed

About

J. Berg is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, J. Berg has authored 12 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in J. Berg's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), CAR-T cell therapy research (2 papers) and Complement system in diseases (2 papers). J. Berg is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), CAR-T cell therapy research (2 papers) and Complement system in diseases (2 papers). J. Berg collaborates with scholars based in Switzerland, United Kingdom and United States. J. Berg's co-authors include Andreas Holbro, Christian Turner, Daniela T. Pilz, Helen V. Firth, David Winkel, Christoph Schlapbach, Nicole Bertschi, Jan–Dirk Studt, Claudia Pfleger and Inga Hegemann and has published in prestigious journals such as Blood, Journal of Medical Genetics and Bone Marrow Transplantation.

In The Last Decade

J. Berg

8 papers receiving 252 citations

Peers

J. Berg

GENET

PRM

SURGE

MARKE

MB

Freya Droege Germany

Luz F. Sua Colombia

Ingrid Kühnle Germany

Ginette Schiby Israel

Subhayan Chattopadhyay Sweden

Zifen Gao China

Christine F. Stephenson United States

Ivana Ilić Croatia

Howard Grodman United States

Marjan Ertault France

Freya Droege Germany

J. Berg

181 ×1.5

GENET

158 ×1.5

PRM

50 ×0.8

SURGE

69 ×1.9

MARKE

75 ×2.3

MB

Citations per year, relative to J. Berg J. Berg (= 1×) peers Freya Droege

Countries citing papers authored by J. Berg

Since Specialization

Citations

This map shows the geographic impact of J. Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Berg more than expected).

Fields of papers citing papers by J. Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Berg. The network helps show where J. Berg may publish in the future.

Co-authorship network of co-authors of J. Berg

This figure shows the co-authorship network connecting the top 25 collaborators of J. Berg. A scholar is included among the top collaborators of J. Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Berg. J. Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Berg, J., Heinz Läubli, Nina Khanna, Lukas T. Jeker, & Andreas Holbro. (2025). Basic Concepts and Indications of CAR T Cells. Hämostaseologie. 45(1). 14–23. 2 indexed citations

2.

Berg, J., et al.. (2025). The Changing Role of Allogeneic Stem Cell Transplantation in Adult B-ALL in the Era of CAR T Cell Therapy. Current Oncology. 32(3). 177–177.

3.

Berg, J., et al.. (2024). Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura - a Case Series with Long-Term Follow-up. Blood. 144(Supplement 1). 4003–4003.

4.

Berg, J., Dominik Heim, Joerg Halter, et al.. (2024). Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(11). 1525–1533.

5.

Berg, J., Jasmin D. Haslbauer, Anna K. Stalder, et al.. (2023). Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies. Research and Practice in Thrombosis and Haemostasis. 7(4). 100182–100182. 9 indexed citations

6.

Recher, Mike, Christian Arranto, Dominik Heim, et al.. (2022). Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case Series. Anticancer Research. 42(9). 4505–4509.

7.

Berg, J., Johanna A. Kremer Hovinga, Claudia Pfleger, et al.. (2021). Daratumumab for immune thrombotic thrombocytopenic purpura. Blood Advances. 6(3). 993–997. 21 indexed citations

8.

Bertschi, Nicole, et al.. (2020). Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome. Journal of the European Academy of Dermatology and Venereology. 35(6). 1331–1337. 30 indexed citations

9.

Turner, Christian, et al.. (2016). Baraitser–Winter cerebrofrontofacial syndrome. Clinical Genetics. 92(1). 3–9. 33 indexed citations

10.

Brouillard, Pascal, Laurence M. Boon, Nicole Revençu, et al.. (2013). Genotypes and Phenotypes of 162 Families with a <b><i>Glomulin</i></b> Mutation. Molecular Syndromology. 4(4). 157–164. 33 indexed citations

11.

Berg, J., et al.. (2003). Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. Journal of Medical Genetics. 40(8). 585–590. 119 indexed citations

12.

Irving, Melita, Frances Elmslie, & J. Berg. (2002). 18. GENETICS OF BREAST CANCER. International Journal of Clinical Practice. 56(9). 677–682. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact